Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tricho-dento-osseous syndrome
(
TDO
), MIM# 190320, is transmitted as a highly penetrant autosomal dominant trait that is characterized by variable clinical expression. The principal clinical features include kinky/curly hair in infancy, enamel hypoplasia, taurodontism, as well as increased thickness and density of cranial bones. Possible genetic linkage has been reported for
TDO
with the ABO blood group locus, but the gene defect remains unknown. We have identified four multiplex families (n = 63, 39 affected, 24 unaffected) from North Carolina segregating
TDO
. We previously have excluded a major locus for
TDO
in the ABO region for these families. Utilizing a genome-wide search strategy, we obtained conclusive evidence for linkage of the
TDO syndrome
locus to markers on chromosome 17q21 (D17S791, Z max = 10.54, Theta = 0.00) with no indication of genetic heterogeneity. Multipoint analysis suggests the
TDO
locus is located in a 7 cM chromosomal segment flanked by D17S932 and D17S941. This finding represents the first step towards isolation and cloning of the
TDO
gene. Identification of this gene has important implications for understanding normal and abnormal craniofacial development of hair, teeth and bone.
Hum
Mol
Genet 1997 Dec
PMID:Genetic linkage of the tricho-dento-osseous syndrome to chromosome 17q21. 936 Oct 34
Tricho-dento-osseous syndrome
(
TDO
) is an autosomal dominant disorder characterized by abnormal hair, teeth and bone. The main clinical manifestations of
TDO
include taurodontism, enamel hypoplasia, kinky, curly hair at birth and increased thickness and density of the cranial bones. These pleiotropic clinical features suggest the role of a developmental gene modulating epithelial-mesenchymal interactions. We recently mapped the
TDO
locus to chromosome 17q21, a region that includes two members of the distal-less homeobox gene family, DLX3 and DLX7. In this paper we describe genomic cloning and sequencing of both human DLX3 and DLX7 and identification of a 4 bp deletion in human DLX3 which correlates with the
TDO
phenotype in six families. The observed mutation is predicted to cause a frameshift and premature termination codon, resulting in a functionally altered DLX3. This first report of a human mutation in the DLX genes is consistent with murine studies indicating their important role in the development of hair, teeth and bone.
Hum
Mol
Genet 1998 Mar
PMID:Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. 946 18